ROBINSON
LOS ANGELES — The doctor of dying plaintiff Eva Echeverria testified Tuesday in the Johnson & Johnson liability trial that she ruled out genetics as a contributing factor to the development of her patient’s ovarian cancer.
Annie Yessaian, a key plaintiff’s witness in the California bellwether trial, said it was more likely than not that Echeverria’s use of the cosmetic company’s baby powder led to developing ovarian cancer.
<...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In




